Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors

Brain Pathology

Volumn 15, Issue 3, 2005, Pages 192-197

  Natté, Remco ^a   Van Eijk, Ronald ^a   Eilers, Paul ^a   Cleton Jansen, Anne Marie ^a   Oosting, Jan ^a   Kouwenhove, Mathilde ^b   Kros, Johan M ^b   Van Duinen, Sjoerd ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOASSAY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; MOLECULAR PROBE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OLIGODENDROGLIOMA; REPRODUCIBILITY;

EID: 23844480688     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2005.tb00520.x     Document Type: Article

References (14)

1. Bigner SH, Matthews MR, Rasheed BKA, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155:375-386.
2. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C, Wainman N, Eisenhauer E (1994) Chemotherapy for Anaplastic Oligodendroglioma. J Clin Oncol 12:2013-2021.
3. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, InoY, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Instit 90:1473-1479.
4. Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892-897.
5. Hatanpaa KJ, Burger PC, Eshleman JR, Murphy KM, Berg KD (2003) Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest 83:419-428.
6. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K (2001) Detection of Ip and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158:1253-1262.
7. Postma C, Hermsen M, Coffa J, Baak J, Mueller J, Mueller E, Bethke B, Scheuten J, Stolte M, Meijer G (2005) Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 205:514-521.
8. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular-genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19Q and 1P. Am J Pathol 145:1175-1190.
9. Scheuten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucl Acids Res 30:e57
10. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB (1999) Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological sub-type. Oncogene 18:4144-4152.
11. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645.
12. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF (1993) Detection of Ip36 Deletions in paraffin sections of neuroblastoma tissues. Genes Chrom Cancer 6:1-9.
13. Van Den Bent MJ, Looijenga LHJ, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Smitt PAS, Jenkins RB, Kros JM (2003) Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 97:1276-1284.
14. Worsham MJ, Pals G, Scheuten JP, Van Spaendonk RM, Concus A, Carey TE, Benninger MS (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:702-708.